Email Updates

Search form

You are here

Browse and Order Resources

Research & Reality calls on funders and researchers to capitalize on lessons learned from a range of recent HIV prevention trials via better problem solving, more critical thinking and coordinated action. This year's AVAC Report identifies progress and gaps in large-scale human trials, rollout of proven options and ongoing research for new advances that women and men will want to use. (View on the web here.)

December, 2013
AVAC
AVAC Report

Released at AIDS 2012, this report lays out a plan for beginning to end HIV/AIDS. It includes clear time-bound outcome targets, as well as the responsibilities of different stakeholders to achieve these targets.

July, 2012
amfAR
AVAC
Report/Issue Brief

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. The 2013 report finds that the US government was again the biggest contributor and calls for other countries and sectors to step up to end a seven-year trend of flat funding. It also profiles growing interest in research on a therapeutic vaccines.

July, 2013
HIV Vaccines & Microbicides Resource Tracking Working Group
AVAC
International AIDS Vaccine Initiative
UNAIDS
Report/Issue Brief

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. The 2012 report finds increased investment by private foundations was unable to make up for the effects of the economic downturn. It also highlights the contributions to prevention research of trial participants.

July, 2012
HIV Vaccines & Microbicides Resource Tracking Working Group
AVAC
International AIDS Vaccine Initiative
UNAIDS
Report/Issue Brief

A comprehensive 2012 report from civil society about the state of voluntary medical male circumcision in Africa. Includes priority recommendations and in-depth discussion of factors influencing national scale-up efforts.  

July, 2012
AVAC
National Empowerment Network of People Living with HIV/AIDS in Kenya
Sonke Gender Justice Network
Uganda Network of AIDS Service Organizations
Report/Issue Brief

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors, and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials. This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials, and Good Participatory Practices in Biomedical HIV Prevention Trials.  The sections provide context, foundational principles, and key practices.  

June, 2011
AVAC
UNAIDS
Handbook/Manual
Training Material

The Handbook provides comprehensive introductory material on the key scientific, policy, social, ethical and economic facets of AIDS vaccine research. While the science has changed greatly over the decade since this second edition of the Handbook was published in 2005, the themes and content in many of the essays still hold true. Edited by Patricia Kahn, the handbook contains articles by community educators and advocates, trial staff and volunteers, scientists and researchers, and policy makers and journalists.

May, 2005
AVAC
Edited by Patricia Kahn
Clinical Trials Process, AIDS Vaccines
Handbook/Manual

A handbook designed to guide the user through various communication scenarios. The handbook offers tips and strategies to navigating difficult scenarios that may occur throughout the clinical trial process.  It also offers suggestions on routine scenarios such as result dissemination and training staff and spokespersons. Read the handbook online at communications4clintrials.org.

February, 2014
FHI 360
Handbook/Manual
Training Material